- Report
- March 2025
- 1400 Pages
Global
From €4297EUR$4,900USD£3,753GBP
- Report
- June 2025
- 109 Pages
Global
From €3025EUR$3,450USD£2,642GBP
- Report
- June 2025
- 198 Pages
Global
From €4340EUR$4,950USD£3,791GBP
- Report
- April 2025
- 225 Pages
Global
From €3946EUR$4,500USD£3,446GBP
- Report
- October 2024
- 124 Pages
Europe
From €4340EUR$4,950USD£3,791GBP
- Report
- August 2025
- 200 Pages
United States
From €2183EUR$2,490USD£1,907GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2543EUR$2,900USD£2,221GBP
- Report
- March 2025
- 260 Pages
Africa
From €2543EUR$2,900USD£2,221GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2543EUR$2,900USD£2,221GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2543EUR$2,900USD£2,221GBP
- Report
- March 2025
- 980 Pages
Europe
From €2543EUR$2,900USD£2,221GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3464EUR$3,950USD£3,025GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €3025EUR$3,450USD£2,642GBP
- Report
- June 2025
- 100 Pages
Europe
From €3464EUR$3,950USD£3,025GBP
- Report
- June 2025
- 89 Pages
North America
From €3025EUR$3,450USD£2,642GBP
- Report
- August 2021
- 50 Pages
United States
From €2104EUR$2,400USD£1,838GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3157EUR$3,600USD£2,757GBP
- Report
- January 2023
- 127 Pages
Global
From €1973EUR$2,250USD£1,723GBP
- Report
- February 2024
- 158 Pages
Global
From €4077EUR$4,650USD£3,561GBP
- Report
- August 2023
- 336 Pages
Global
From €4077EUR$4,650USD£3,561GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more